Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy

Y Gong, RGJ Klein Wolterink, J Wang, GMJ Bos… - Journal of hematology & …, 2021 - Springer
Due to their efficient recognition and lysis of malignant cells, natural killer (NK) cells are
considered as specialized immune cells that can be genetically modified to obtain capable …

Gene therapy using haematopoietic stem and progenitor cells

G Ferrari, AJ Thrasher, A Aiuti - Nature Reviews Genetics, 2021 - nature.com
Haematopoietic stem and progenitor cell (HSPC) gene therapy has emerged as an effective
treatment modality for monogenic disorders of the blood system such as primary …

High-efficiency transgene integration by homology-directed repair in human primary cells using DNA-PKcs inhibition

S Selvaraj, WN Feist, S Viel, S Vaidyanathan… - Nature …, 2024 - nature.com
Therapeutic applications of nuclease-based genome editing would benefit from improved
methods for transgene integration via homology-directed repair (HDR). To improve HDR …

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells

S Ferrari, A Jacob, D Cesana, M Laugel, S Beretta… - Cell Stem Cell, 2022 - cell.com
Long-range gene editing by homology-directed repair (HDR) in hematopoietic
stem/progenitor cells (HSPCs) often relies on viral transduction with recombinant adeno …

Cas9 activates the p53 pathway and selects for p53-inactivating mutations

OM Enache, V Rendo, M Abdusamad, D Lam… - Nature …, 2020 - nature.com
Cas9 is commonly introduced into cell lines to enable CRISPR–Cas9-mediated genome
editing. Here, we studied the genetic and transcriptional consequences of Cas9 expression …

Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response

G Schiroli, A Conti, S Ferrari, L Della Volpe, A Jacob… - Cell stem cell, 2019 - cell.com
Precise gene editing in hematopoietic stem and progenitor cells (HSPCs) holds promise for
treating genetic diseases. However, responses triggered by programmable nucleases in …

Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy

S Ferrari, E Valeri, A Conti, S Scala, A Aprile… - Cell Stem Cell, 2023 - cell.com
The growing clinical success of hematopoietic stem/progenitor cell (HSPC) gene therapy
(GT) relies on the development of viral vectors as portable" Trojan horses" for safe and …

TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening

MM Álvarez, J Biayna, F Supek - Nature communications, 2022 - nature.com
CRISPR/Cas9 gene editing can inactivate genes in a precise manner. This process involves
DNA double-strand breaks (DSB), which may incur a loss of cell fitness. We hypothesize that …

[HTML][HTML] DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes

AMS Giordano, M Luciani, F Gatto… - Journal of Experimental …, 2022 - rupress.org
Aberrant induction of type I IFN is a hallmark of the inherited encephalopathy Aicardi-
Goutières syndrome (AGS), but the mechanisms triggering disease in the human central …

Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges

M Cavazzana, FD Bushman, A Miccio… - Nature reviews Drug …, 2019 - nature.com
Pioneering gene therapy trials have shown that the genetic engineering of haematopoietic
stem and progenitor cells can be an alternative to allogeneic transplantation in the treatment …